Panel Discussion: How to Monitor and Minimize Variation and Mistakes (Clinical Chemistry Forum) (Discussion)
Clinical Chemistry 1997, May, 43, 5
-
- €2.99
-
- €2.99
Publisher Description
Panel II of the 1996 Clinical Chemistry Forum was a discussion initiated by brief formal presentations from Rosemary Bakes-Martin of the US Centers for Disease Control and Prevention (CDC), Cornelia Rooks of the US Food and Drug Administration (FDA), William Hamlin of the College of American Pathologists (CAP), Nathan Gochman of Beckman Instruments, and David Witte of this Forum Committee. Initial Presentations
Quality: The Next Six Months (Clinical Chemistry Forum)
1997
Analytical Performance Characteristics should be Judged Against Objective Quality Specifications (Editorial)
1999
Laboratory Medicine: Challenges and Opportunities (Opinion)
2007
Pharmaceutical Analysis for Small Molecules
2017
Pharmaceutical Quality by Design
2018
Strategies for Effective Improvements to the BioWatch System
2018
Impact of the Third Cholesterol Report from the Adult Treatment Panel of the National Cholesterol Education Program on the Clinical Laboratory (Special Report)
2002
DNA Methylation Changes in Sera of Women in Early Pregnancy are Similar to Those in Advanced Breast Cancer Patients (Technical Briefs)
2004
Colorectal Carcinoma Susceptibility and Metastases are Associated with Matrix Metalloproteinase-7 Promoter Polymorphisms (Technical Briefs)
2003
High-Sensitivity C-Reactive Protein As a Predictor of All-Cause Mortality: Implications for Research and Patient Care (Editorial)
2008
Biological Variation of Tumor Markers and Its Application in the Detection of Disease Progression in Patients with Non-Small Cell Lung Cancer (Technical Briefs)
2005
Hemoglobin Variants and Hemoglobin [a.Sub.1C] Analysis: Problem Solved?(Editorial)
2003